SEC Form 4 · accession 0001179110-17-006201
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Apr 21, 2017
Accepted (ET)
Apr 25, 2017 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depository Shares representing Common SharesF1 | Apr 21, 2017 | S | 2,622 | $11.0364 | D | 2,609,901 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depository Share of the Issuer ("ADS") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs.